Alphasimplex Group, LLC Alnylam Pharmaceuticals, Inc. Transaction History

Alphasimplex Group, LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2021 Aug 12, 2021	SELL	$128.63 - $176.89 $193,974 - $266,750	-1,508 Closed	0 $0
Q1 2021 May 12, 2021	SELL	$126.83 - $175.69 $59,863 - $82,925	-472 Reduced 23.84%	1,508 $213,000
Q4 2020 Feb 12, 2021	SELL	$122.97 - $147.0 $52,262 - $62,475	-425 Reduced 17.67%	1,980 $257,000
Q3 2020 Nov 13, 2020	BUY	$121.19 - $165.49 $100,345 - $137,025	828 Added 52.5%	2,405 $350,000
Q2 2020 Aug 14, 2020	BUY	$104.21 - $156.44 $164,339 - $246,705	1,577 New	1,577 $234,000

644

109M

1.28M

1.21M

Ticker ALNY
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 123,028,000
Market Cap $31.3B
Description
Alnylam Pharmaceuticals, Inc., a biopharmaceutical company, focuses on discovering, developing, and commercializing novel therapeutics based on ribonucleic acid interference. The company's pipeline of investigational RNAi therapeutics focuses on genetic medicines, cardio-metabolic diseases, hepatic infectious diseases, and central nervous system...

Get notified when there are updates to the investment portfolio of Alphasimplex Group, LLC, based on Form 13F filings with the SEC.

Stay updated on Alphasimplex Group, LLC with notifications on news.